# Vaccination of Advanced-Stage Lung Cancer Patients

> **NCT02264236** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Lung Neoplasms

## Interventions

- **BIOLOGICAL:** P10s-PADRE vaccine

## Key facts

- **NCT ID:** NCT02264236
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-10
- **Primary completion:** 2021-06
- **Final completion:** 2021-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to enroll subjects under current iteration of the protocol
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264236, "Vaccination of Advanced-Stage Lung Cancer Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02264236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*